Stay updated with breaking news from Genomic Diagnostic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Healius Limited (ASX:HLS – Get Free Report) insider Kathryn (Kate) McKenzie bought 53,000 shares of Healius stock in a transaction on Monday, December 4th. The stock was acquired at an average cost of A$1.52 ($1.01) per share, with a total value of A$80,560.00 ($53,350.99). Healius Stock Performance The company has a current ratio of 0.55, […]
In this comprehensive blog post, we will explore the fascinating world of genomic diagnostic testing, covering its principles, applications...
Healius Limited (ASX:HLS – Get Free Report) insider Jennifer (Jenny) Macdonald acquired 8,000 shares of the firm’s stock in a transaction dated Monday, September 11th. The shares were purchased at an average price of A$2.53 ($1.63) per share, with a total value of A$20,232.00 ($13,052.90). Healius Stock Performance The company has a quick ratio of […]
/PRNewswire/ -- MedGenome, a leading global Genomic Diagnostic and Research Services company in South Asia, becomes the first to offer advanced genomics...